Jul 18,2019

Vine Health Raises £1.2M in Seed Funding

Vine Health, a London, UK-based provider of an app that helps cancer patients manage and understand their treatment and lifestyle, raised �1.2m in seed funding. The round was led by Playfair Capital, with participation from Entrepreneur First, Ascension Ventures and Tiny VC, as well as a number of angel investors including Simon and Michael Blakey and Pam Garside. The company will use the funds to develop its platform and make key hires at its headquarters.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 24,2019

PathAI Receives Strategic Investment from LabCorp

PathAI, a Boston, MA-based provider of artificial intelligence-powered technology for use in pathology research, secured an investment from LabCorp (NYSE: LH), a global life sciences company. The amount of the deal was not disclosed. The company intends to use the funds to expand clinical development of artificial intelligence-enabled computational pathology and advance its eventual integration with clinical laboratories. LabCorp�s investment follows a $60m round of funding into PathAI announced last month, led by global growth equity firm General Atlantic and venture capital firm General Catalyst.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 08,2019

SidekickHealth receives an injection from Novator

Novator, Björgólf Thor Björgólfsson's investment company, and related investors have completed a one hundred million ISK injection into the Icelandic health technology company SidekickHealth, but the investor group has contributed hundreds of millions to the company since its inception. SidekickHealth has one foot in the door of the global pharmaceutical industry after successfully partnering with two of the world's five largest pharmaceutical companies. A second and larger capital increase is planned for the end of the year.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 29,2019

This French startup just raised €1.8M to combat loneliness in chronic disease

Wefight has just raised €1.8 million to accelerate the development of its virtual companion technology, which combats loneliness in patients with chronic diseases. The funds secured through the EIT Health network were provided by Investir&+, Angels Santé, Business Angels des Grandes Écoles, and MELIES Business Angels.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

Insilico Medicine Raises $37M in Series B Funding

Insilico Medicine, a Hong Kong-based developer of next-generation artificial intelligence technology for drug discovery, completed a $37m Series B funding round. The round was led by Qiming Venture Partners, joined by Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital, Bold Capital Partners and others. The company intends to use the funds to: � commercialize the validated generative chemistry and target identification technology, � build up a senior management team with the experience in the pharmaceutical industry, � further develop its pipeline in cancer, fibrosis, NASH, immunology and CNS for the purposes of partnering with the pharmaceutical companies on specific therapeutic programs.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 17,2019

BenevolentAI Announces $90 Million Investment From Temasek

BenevolentAI, the leader in the creation and application of AI and machine learning to transform the way medicines are discovered and developed, today announces that it has raised $90 million from Temasek, a Singapore-headquartered investment company. Raine Advisors acted as exclusive financial advisors to BenevolentAI. The funding will be used to scale and further develop the Benevolent Platform for drug discovery and development. BenevolentAI will continue to advance its growing pipeline of internal drug development programmes and collaborations with strategic partners across its key therapeutic areas. Most recently, BenevolentAI announced long-term collaborations with AstraZeneca and Novartis, which will generate meaningful revenues for BenevolentAI over a multi-year period.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 05,2019

Bayer leads $25m investment round for healthcare start-up Medopad

Digital healthcare start-up Medopad has earned $25m in an investment round led by Leaps by Bayer, the German pharmaceutical multinational�s venture capital arm. The investment, which brings Medopad�s total funding to over $50m, will be used to help develop the company�s digital health platform and to fund new clinical studies.The investment will support clinical trials on these conditions, as well as heart condition Aortic Stenosis.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 14,2019

Careology raises GBP1.2m to fund growth plans

Careology, a health-tech platform for cancer care, has raised GBP1.12 million in funding from some of the UK�s leading health and technology private angel investors.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 13,2020

Concerto HealthAI Raises $150 Million in Series B Funding

Concerto HealthAI, the market leader for Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology, announced today it has raised $150 million in aggregate Series B financing. The round of financing was led by Declaration Partners with participation from Maverick Ventures, AllianceBernstein PCI, and SymphonyAI Group. As part of the transaction, Andrew Goldfarb, partner at Declaration Partners, and Leif Pedersen, senior operating partner at SymphonyAI Group, will join Concerto HealthAI�s board. Romesh Wadhwani, founder and CEO of SymphonyAI Group, will continue as executive chairman, and Jeff Elton, PhD, CEO of Concerto HealthAI as board member. The Series B funding will support Concerto HealthAI�s continued innovation in RWD and technology products and services for regulatory and non-regulatory applications, expansion into adjacent therapy areas, and commercial patient solutions.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 10,2020

SkinVision has raised an investment from Rubio Impact Ventures

Jones Day advised SkinVision on the investment by Rubio Impact Ventures and existing shareholders.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING